CSL Stock Analysis: Carlisle Companies | NYSE
Building Products & Equipment | NYSE, USA | Market Cap: 12.966m USD | 12M Return: 4.4% | US1423391002 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 154M
EPS Trend: 76.5%
Qual. Beats: 1
Rev. Trend: 69.2%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Carlisle Companies Incorporated (NYSE: CSL) is a U.S.-headquartered manufacturer and supplier of building envelope products and solutions, serving commercial and residential construction markets in the United States, Europe, and internationally. The company operates through two core segments: Carlisle Construction Materials (CCM), which produces single-ply roofing membranes, polyiso insulation, and engineered metal roofing and wall panel systems, and Carlisle Weatherproofing Technologies (CWT), which offers waterproofing, air/vapor barriers, sealants, roof coatings, spray polyurethane foam, EPS insulation, and HVAC-related products. Carlisle sells its products under several established brands, including Carlisle SynTec, Versico, WeatherBond, Hunter Panels, Resitrix, and Hertalan. Founded in 1917 and headquartered in Scottsdale, Arizona, the company is classified as an Industrial Conglomerate within the Industrials sector, reflecting its diversified portfolio of construction-focused manufacturing businesses.
The building envelope products industry is closely tied to commercial and residential building activity, with demand influenced by new construction starts, renovation cycles, and energy efficiency standards. Companies in this space typically generate revenue across multiple product categories serving both new builds and retrofit applications.
- Commercial construction demand boosts single-ply roofing volumes
- Resin and polyiso raw material costs pressure margins
- Weatherproofing Technologies segment expands via acquisitions
| Net Income: 724.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA -1.66 > 1.0 |
| NWC/Revenue: 27.74% < 20% (prev 16.59%; Δ 11.15% < -1%) |
| CFO/TA 0.16 > 3% & CFO 1.01b > Net Income 724.5m |
| Net Debt (2.32b) to EBITDA (1.25b): 1.86 < 3 |
| Current Ratio: 2.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (40.8m) vs 12m ago -7.27% < -2% |
| Gross Margin: 35.26% > 18% (prev 36.92%; Δ -1.66% > 0.5%) |
| Asset Turnover: 86.73% > 50% (prev 90.62%; Δ -3.89% > 0%) |
| Interest Coverage Ratio: 10.05 > 6 (EBIT TTM 1.05b / Interest Expense TTM 104.7m) |
| A: 0.23 (Total Current Assets 2.30b - Total Current Liabilities 883.4m) / Total Assets 6.23b |
| B: 1.22 (Retained Earnings 7.63b / Total Assets 6.23b) |
| C: 0.18 (EBIT TTM 1.05b / Avg Total Assets 5.88b) |
| D: 0.35 (Book Value of Equity 1.62b / Total Liabilities 4.62b) |
| Altman-Z'' = 7.04 = AAA |
| DSRI: 1.06 (Receivables 955.9m/881.7m, Revenue 5.10b/5.00b) |
| GMI: 1.05 (GM 36.92% / 35.26%) |
| AQI: 0.85 (AQ_t 0.50 / AQ_t-1 0.58) |
| SGI: 1.02 (Revenue 5.10b / 5.00b) |
| TATA: -0.05 (NI 724.5m - CFO 1.01b) / TA 6.23b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of October 19, 2026, the stock is trading at USD 333.86 with a total of 451,605 shares traded. Over the past week, the price has changed by +4.21%, over one month by +4.21%, over three months by -3.00% and over the past year by +4.44%.
Current recommended Stop Loss: 318.00 (which is 4.8% or 1.5 ATR below the current price).
Carlisle Companies has received a consensus analysts rating of 3.80. Therefore, it is recommended to hold CSL.
- StrongBuy: 3
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 400.9 | 20.1% |
P/E Trailing = 18.6993
P/E Forward = 13.4953
P/S = 2.5439
P/B = 7.9556
P/EG = 0.8999
Revenue TTM = 5.10b USD
EBIT TTM = 1.05b USD
EBITDA TTM = 1.25b USD
Long Term Debt = 2.88b USD (from longTermDebt, last quarter)
Short Term Debt = 4.90m USD (from shortTermDebt, two quarters ago)
Debt = 2.99b USD (from shortLongTermDebtTotal, last quarter) + Leases 100.5m
Net Debt = 2.32b USD (calculated: Debt 2.99b - CCE 665.3m)
Enterprise Value = 15.3b USD (13.0b + Debt 2.99b - CCE 665.3m)
Interest Coverage Ratio = 10.05 (Ebit TTM 1.05b / Interest Expense TTM 104.7m)
EV/FCF = 17.64x (Enterprise Value 15.3b / FCF TTM 866.6m)
FCF Yield = 5.67% (FCF TTM 866.6m / Enterprise Value 15.3b)
FCF Margin = 17.00% (FCF TTM 866.6m / Revenue TTM 5.10b)
Net Margin = 14.21% (Net Income TTM 724.5m / Revenue TTM 5.10b)
Gross Margin = 35.26% ((Revenue TTM 5.10b - Cost of Revenue TTM 3.30b) / Revenue TTM)
Gross Margin QoQ = 36.20% (prev 34.52%)
Tobins Q-Ratio = 2.45 (Enterprise Value 15.3b / Total Assets 6.23b)
Interest Expense / Debt = 3.51% (Interest Expense 104.7m / Debt 2.99b)
Taxrate = 22.68% (214.8m / 947.1m)
NOPAT = 813.3m (EBIT 1.05b * (1 - 22.68%))
Current Ratio = 2.60 (Total Current Assets 2.30b / Total Current Liabilities 883.4m)
Debt / Equity = 1.85 (Debt 2.99b / totalStockholderEquity, last quarter 1.62b)
Debt / EBITDA = 1.86 (Net Debt 2.32b / EBITDA 1.25b)
Debt / FCF = 2.68 (Net Debt 2.32b / FCF TTM 866.6m)
Total Stockholder Equity = 1.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.33% (Net Income 724.5m / Total Assets 6.23b)
RoE = 41.06% (Net Income TTM 724.5m / Total Stockholder Equity 1.76b)
RoCE = 22.62% (EBIT 1.05b / Capital Employed (Equity 1.76b + L.T.Debt 2.88b))
RoIC = 15.96% (NOPAT 813.3m / Invested Capital 5.10b)
WACC = 8.16% (E(13.0b)/V(16.0b) * Re(9.41%) + D(2.99b)/V(16.0b) * Rd(3.51%) * (1-Tc(0.23)))
Discount Rate = 9.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.50 | Cagr: -7.31%
[DCF] Terminal Value 75.56% ; FCFF base≈863.4m ; Y1≈873.7m ; Y5≈939.9m
[DCF] Fair Price = 309.1 (EV 14.6b - Net Debt 2.32b = Equity 12.3b / Shares 39.7m; r=8.35% [WACC [floored]]; 5y FCF grow 0.93% → 2.50% )
EPS Correlation: 76.48 | EPS CAGR: 6.73% | SUE: 2.64 | # QB: 1
Revenue Correlation: 69.23 | Revenue CAGR: 2.18% | SUE: 3.29 | # QB: 1
EPS current Quarter (2026-09-30): EPS=5.91 | Chg30d=-0.74% | Revisions=-25% | Analysts=10
EPS current Year (2026-12-31): EPS=21.09 | Chg30d=-0.63% | Revisions=-40% | GrowthEPS=+8.7% | GrowthRev=+4.8%
EPS next Year (2027-12-31): EPS=23.95 | Chg30d=-0.53% | Revisions=-40% | GrowthEPS=+13.6% | GrowthRev=+5.0%
[Analyst] Revisions Ratio: -62% (up=0, down=5)